Literature DB >> 2542856

The plasma renin-angiotensin system in preeclampsia: effects of magnesium sulfate.

S L Sipes1, C P Weiner, T M Gellhaus, J D Goodspeed.   

Abstract

Two groups of women were studied in a prospective longitudinal fashion to determine the effects of a 2.5-hour infusion of magnesium sulfate upon the renin-angiotensin system. Serum magnesium concentration, angiotensin-converting enzyme concentration, and plasma renin activity were measured at uniform intervals in women with either preeclampsia or preterm labor. Plasma renin activity was significantly lower (3.9 +/- 2.2 versus 6.1 +/- 1.8 ng/mL/minute; P = .004) and angiotensin-converting enzyme significantly higher (47.1 +/- 14 versus 34.0 +/- 10 U/mL; P = .008) in women with preeclampsia than in those with preterm labor. Magnesium infusion was associated with a sustained decline in plasma renin activity in preeclamptic women (P = .003). A transient decline in angiotensin-converting enzyme (P = .009) was observed in women with preeclampsia, but not with preterm labor. In contrast to the sustained change in plasma renin activity, angiotensin-converting enzyme concentration returned to baseline activity levels by 2.5 hours. A nonsignificant negative relationship (P = .06) was noted between angiotensin-converting enzyme and gestational age in subjects with preeclampsia. We conclude that a short-term infusion of magnesium sulfate leads to a sustained decline in plasma renin activity in preeclamptic women, but exerts no sustained effect on angiotensin-converting enzyme in women with either preeclampsia or preterm labor.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2542856     DOI: 10.1097/00006250-198906000-00005

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  4 in total

Review 1.  Hypomagnesemia and hypermagnesemia.

Authors:  Joel Michels Topf; Patrick T Murray
Journal:  Rev Endocr Metab Disord       Date:  2003-05       Impact factor: 6.514

2.  Severe hyperkalaemia peripartum with magnesium sulphate.

Authors:  Adam Morton
Journal:  Obstet Med       Date:  2012-01-27

Review 3.  Role of magnesium sulfate in seizure prevention in patients with eclampsia and pre-eclampsia.

Authors:  J Anthony; R B Johanson; L Duley
Journal:  Drug Saf       Date:  1996-09       Impact factor: 5.606

4.  Anesthesia and Intensive Care Management in a Pregnant Woman with PRES: A Case Report.

Authors:  Ismail Demirel; Ayse Belin Ozer; Mustafa K Bayar; Salih Burcin Kavak
Journal:  Case Rep Anesthesiol       Date:  2012-07-05
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.